Promis Neurosciences (PMN)
(Delayed Data from NSDQ)
$1.37 USD
+0.07 (5.09%)
Updated Aug 30, 2024 03:41 PM ET
After-Market: $1.34 -0.03 (-1.92%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth F Momentum F VGM
Cash flow Statements
Fiscal Year End for Promis Neurosciences falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -13.21 | -18.06 | -9.40 | -4.23 | -5.57 |
Depreciation/Amortization & Depletion | 0.02 | 0.01 | 0.05 | 0.01 | 0.01 |
Net Change from Assets/Liabilities | 2.94 | 5.40 | -1.59 | 0.66 | 0.49 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -0.60 | -4.39 | 1.50 | 0.31 | 0.49 |
Net Cash From Operating Activities | -10.84 | -17.03 | -9.45 | -3.25 | -4.59 |
Property & Equipment | 0.00 | 0.00 | 0.09 | -0.08 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.10 | -0.08 | 0.00 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 17.75 | 6.49 | 20.36 | 2.86 | 4.51 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 6.95 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | -1.67 | 0.00 | -0.47 |
Net Cash from Financing Activities | 17.75 | 6.49 | 25.64 | 2.86 | 4.04 |
Effect of Exchange Rate Changes | -0.18 | -0.53 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 6.72 | -11.07 | 16.29 | -0.47 | -0.55 |
Cash at Beginning of Period | 5.88 | 16.94 | 0.82 | 1.24 | 1.80 |
Cash at End of Period | 12.60 | 5.88 | 17.11 | 0.77 | 1.25 |
Diluted Net EPS | -1.07 | -2.41 | -1.43 | -0.89 | -1.35 |
Fiscal Year End for Promis Neurosciences falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.26 | -3.64 | -13.21 | -9.63 | -7.27 |
Depreciation/Amortization & Depletion | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
Net Change from Assets/Liabilities | -5.57 | -6.73 | 2.94 | 2.96 | 2.90 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 0.04 | 0.08 | -0.60 | -0.42 | -0.34 |
Net Cash From Operating Activities | -11.80 | -10.29 | -10.84 | -7.09 | -4.71 |
Property & Equipment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.19 | 0.19 | 17.75 | 18.26 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 0.19 | 0.19 | 17.75 | 18.26 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | -0.18 | -0.18 | 0.06 |
Net Change In Cash & Equivalents | -11.61 | -10.10 | 6.72 | 10.99 | -4.65 |
Cash at Beginning of Period | 12.60 | 12.60 | 5.88 | 5.88 | 5.88 |
Cash at End of Period | 0.99 | 2.50 | 12.60 | 16.87 | 1.22 |
Diluted Net EPS | -0.13 | -0.19 | -0.03 | -0.19 | -0.27 |